Atrial fibrillation as a risk factor in patients after cardiac arrest for ventricular fibrillation

被引:0
|
作者
Smid, Jiri [1 ]
Vancura, Vlastimil [1 ]
Rokyta, Richard [1 ]
机构
[1] Univ Karlova, Fak Nemocnice Plzen, Lekarska Fak Plzen, Komplexni Kardiovaskularni Ctr,Kardiol Klin, Alej Svobody 80, Plzen 30460, Czech Republic
关键词
Acute coronary syndrome; Atrial fibrillation; Epidemiology; Sudden cardiac death; Ventricular fibrillation;
D O I
10.33678/cor.2022.025
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Atrial fibrillation is the most common arrhythmia in adults. Several studies were focused on the association between atrial fibrillation and other heart diseases, including sudden cardiac death. Aim: The aim of our study was to analyse the incidence of atrial fibrillation as a risk factor after sudden cardiac arrest for ventricular fibrillation. Methods: Retrospective, monocentric study included 514 people after out-of-hospital cardiac arrest (OHCA) hospitalized in the Cardiology Intensive Care Unit. Patients underwent standard post-resuscitation man-agement (including coronary angiography and echocardiography). The case history of patients was found (comorbidities, medication, and presence of atrial fibrillation before the actual OHCA). These data were further evaluated then. Results: A higher incidence of atrial fibrillation was clearly demonstrated in comparison of patients with cardiac arrest due to ventricular fibrillation without ACS (VF without ACS) compared to the patients with ACS (total incidence AF 106 pts., 45.96% x 24 pts., 13.95%, p <0.0001). There were statistically more patients with already known coronary artery disease and arterial hypertension in the group of VF without ACS and patients used statistically significantly more ACEi/sartans, beta-blockers, digoxin, diuretics, antiplatelet and anticoagulant therapy, and statins. A comparison of patients with cardiac arrest due to ventricular fibrilla-tion with acute coronary syndrome and coronary artery disease (VF with ACS with CAD) with patients with ventricular fibrillation without acute coronary syndrome and without coronary artery disease (VF without ACS without CAD) showed a statistically significantly higher incidence of total atrial fibrillation in the VF group without ACS and without CAD (45 pts., 39.13% x 4 pts., 16.67%, p = 0.0376). There was no significant difference in the monitored comorbidities. There was a significant difference in the use of beta-blockers, an-tiplatelet therapy and statins in the monitored medication, which is due to the presence of coronary artery disease before cardiac arrest. Conclusion: Our investigation confirmed atrial fibrillation as a significant risk factor for sudden cardiac death in patients with cardiac arrest without acute coronary syndrome compared to patients with acute coronary syndrome. Similarly, it confirms a higher incidence of atrial fibrillation in patients after cardiac arrest due to ventricular fibrillation without coronary artery disease and acute coronary syndrome compared to patients with these diseases. This confirms atrial fibrillation as an independent risk factor for sudden cardiac death.
引用
收藏
页码:282 / 289
页数:8
相关论文
共 50 条
  • [31] Is Pre Existing Atrial Fibrillation a Risk Factor for Contrast Induced Nephropathy After Cardiac Catheterization?
    Sedhai, Yub Raj
    Choksi, Tatvam
    Asija, Ankush
    Ahangar, Waseem
    Gevorgyan, David
    Golamari, Reshma
    Borikar, Madhura
    Missri, Jose
    CIRCULATION, 2016, 134
  • [32] Is Pre Existing Atrial Fibrillation a Risk Factor for Contrast Induced Nephropathy After Cardiac Catheterization?
    Sedhai, Yub Raj
    Choksi, Tatvam
    Asija, Ankush
    Ahangar, Waseem
    Gevorgyan, David
    Golamari, Reshma
    Borikar, Madhura
    CIRCULATION, 2016, 134
  • [33] Nitrite pharmacokinetics, safety and efficacy after experimental ventricular fibrillation cardiac arrest
    Uray, Thomas
    Empey, Philip E.
    Drabek, Tomas
    Stezoski, Jason P.
    Janesko-Feldman, Keri
    Jackson, Travis
    Garman, Robert H.
    Kim, Francis
    Kochanek, Patrick M.
    Dezfulian, Cameron
    NITRIC OXIDE-BIOLOGY AND CHEMISTRY, 2019, 93 : 71 - 77
  • [34] Influence of Race on Atrial Fibrillation After Cardiac Surgery
    Rader, Florian
    Van Wagoner, David R.
    Ellinor, Patrick T.
    Gillinov, A. Marc
    Chung, Mina K.
    Costantini, Otto
    Blackstone, Eugene H.
    CIRCULATION-ARRHYTHMIA AND ELECTROPHYSIOLOGY, 2011, 4 (05) : 644 - U107
  • [35] Ventricular Fibrillation in Cardiac Arrest with Nonshockable Initial Rhythm
    Rosell-Ortiz, Fernando
    Mellado-Vergel, Francisco J.
    Fernandez-Valle, Patricia
    Caballero-Garcia, Auxiliadora
    Gonzalez-Lobato, Ismael
    Vergara-Perez, Santiago
    Ruiz-Montero, Maria M.
    Martinez-Lara, Manuela
    Vivar-Diaz, Itziar
    del Aguila, Javier Garcia
    CIRCULATION, 2014, 130
  • [36] Postoperative atrial fibrillation after aortic valve replacement is a risk factor for long-term atrial fibrillation
    Carter-Storch, Rasmus
    Dahl, Jordi S.
    Christensen, Nicolaj L.
    Pecini, Redi
    Sondergard, Eva V.
    Ovrehus, Kristian Altern
    Moller, Jacob E.
    INTERACTIVE CARDIOVASCULAR AND THORACIC SURGERY, 2019, 29 (03) : 378 - 385
  • [37] Inflammatory cytokines in cardiac pacing patients with atrial fibrillation and asymptomatic atrial fibrillation
    Pan, Jiaxi
    Wang, Weiwei
    Wu, Xiaoxue
    Kong, Fanqi
    Pan, Jialin
    Lin, Jiafeng
    Zhang, Minxue
    PANMINERVA MEDICA, 2018, 60 (03) : 86 - 91
  • [38] Prediabetes: An overlooked risk factor for major adverse cardiac and cerebrovascular events in atrial fibrillation patients
    Desai, Rupak
    Katukuri, Nishanth
    Goguri, Sumaja Reddy
    Kothawala, Azra
    Alle, Naga Ruthvika
    Bellamkonda, Meena Kumari
    Dey, Debankur
    Ganesan, Sharmila
    Biswas, Minakshi
    Sarkar, Kuheli
    Prattipati, Pramoda
    Chauhan, Shaylika
    WORLD JOURNAL OF DIABETES, 2024, 15 (01) : 24 - 33
  • [39] Safety and efficacy of landiolol hydrochloride for prevention of atrial fibrillation after cardiac surgery in patients with left ventricular dysfunction: Prevention of Atrial Fibrillation After Cardiac Surgery With Landiolol Hydrochloride for Left Ventricular Dysfunction (PLATON) trial
    Sezai, Akira
    Osaka, Shunji
    Yaoita, Hiroko
    Ishii, Yusuke
    Arimoto, Munehito
    Hata, Hiroaki
    Shiono, Motomi
    JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2015, 150 (04) : 957 - 964
  • [40] Relationship Between Right Ventricular Function and Atrial Fibrillation After Cardiac Surgery
    Ting, Pei-Chi
    Chou, An-Hsun
    Wu, Victor Chien-Chia
    Tsai, Feng-Chun
    Chu, Jaw-Ji
    Chen, Chun-Yu
    Lan, Tzuo-Yun
    Chen, Shao-Wei
    JOURNAL OF CARDIOTHORACIC AND VASCULAR ANESTHESIA, 2017, 31 (05) : 1663 - 1671